Skip to content
NBlaz – Lifestyle
Author:
Humacyte, Inc
Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026
May 8, 2026
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026
April 27, 2026
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
April 24, 2026
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
April 22, 2026
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair
April 21, 2026
←
Previous Page
1
2
3